There was significantly reduced levels of secreted circulating Clusterin in COPD compared with healthy age-matched controls (Fig. 1C), suggesting that increased Clusterin in the circulation was specific to IPF. The gene discussed is CLU; the disease is idiopathic pulmonary fibrosis.